Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Entrada Therapeutics, Inc.”

5 pharma patents match "Entrada Therapeutics, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 5
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 5 pharmaceutical patents matching "Entrada Therapeutics, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

5 results for “Entrada Therapeutics, Inc.” · 30,257 patents in full index Clear search

  1. US 11987821

    Compositions and methods for treating mitochondrial neurogastrointestinal encephalopathy

    Entrada Therapeutics, Inc. · Granted May 21, 2024 · Expires May 16, 2044

    granted
  2. US 11225506

    Cell penetrating peptides and methods of making and using thereof

    Entrada Therapeutics, Inc. · Granted Jan 18, 2022 · Expires Jan 13, 2042

    granted
  3. US 11168310

    Compositions and methods for treating mitochondrial neurogastrointestinal encephalopathy

    Entrada Therapeutics, Inc. · Granted Nov 9, 2021 · Expires Nov 4, 2041

    granted
  4. US 10815276

    Cell penetrating peptides and methods of making and using thereof

    Entrada Therapeutics, Inc. · Granted Oct 27, 2020 · Expires Oct 22, 2040

    granted
  5. US 10626147

    Cell penetrating peptides and methods of making and using thereof

    Entrada Therapeutics, Inc. · Granted Apr 21, 2020 · Expires Apr 16, 2040

    granted